摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-ethyl-7-ethoxy-2-(3-quinolylmethylenehydrazino)quinoline

中文名称
——
中文别名
——
英文名称
4-ethyl-7-ethoxy-2-(3-quinolylmethylenehydrazino)quinoline
英文别名
7-ethoxy-4-ethyl-N-[(E)-quinolin-3-ylmethylideneamino]quinolin-2-amine
4-ethyl-7-ethoxy-2-(3-quinolylmethylenehydrazino)quinoline化学式
CAS
——
化学式
C23H22N4O
mdl
——
分子量
370.454
InChiKey
AESPNXNGSIVEMI-MFKUBSTISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    28
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    59.4
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Compounds and methods for diagnosing and treating amyloid-related conditions
    申请人:Pharmacia & Upjohn Company
    公开号:US20030219377A1
    公开(公告)日:2003-11-27
    The invention provides methods for diagnosing and treating amyloid-related conditions and compounds useful for the same. The invention provides for detecting, imaging, monitoring, diagnosing, and treating conditions characterized by the binding or aggregation of amyloid fibrils. More particularly, the invention relates to using quinolinehydrazone compounds for diagnosing and treating amyloidotic conditions and also as an antioxidant.
    本发明提供了诊断和治疗淀粉样蛋白相关疾病的方法以及用于诊断和治疗淀粉样蛋白相关疾病的化合物。本发明提供了检测、成像、监测、诊断和治疗以淀粉样纤维结合或聚集为特征的病症的方法。更具体地说,本发明涉及使用喹啉腙化合物诊断和治疗淀粉样变性病症,并用作抗氧化剂
  • COMPOUNDS AND METHODS FOR DIAGNOSING AND TREATING AMYLOID-RELATED CONDITIONS
    申请人:PHARMACIA & UPJOHN COMPANY
    公开号:EP1318982A1
    公开(公告)日:2003-06-18
  • US6589504B1
    申请人:——
    公开号:US6589504B1
    公开(公告)日:2003-07-08
  • [EN] COMPOUNDS AND METHODS FOR DIAGNOSING AND TREATING AMYLOID-RELATED CONDITIONS<br/>[FR] COMPOSES ET PROCEDES PERMETTANT DE DIAGNOSTIQUER ET DE TRAITER DES CONDITIONS LIEES AUX AMYLOIDES
    申请人:UPJOHN CO
    公开号:WO2002024652A1
    公开(公告)日:2002-03-28
    The invention provides methods for diagnosing and treating amyloid-related conditions and compounds useful for the same. The invention provides for detecting, imaging, monitoring, diagnosing, and treating conditions characterized by the binding or aggregation of amyloid fibrils. More particularly, the invention relates to using quinolinehydrazone compounds for diagnosing and treating amyloidotic conditions and also as an antioxidant.
查看更多